Indication
Transfusion-Dependent Beta Thalassemia
The Transfusion-Dependent Beta Thalassemia pipeline: 3 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Transfusion-Dependent Beta Thalassemia, so this list is not complete.
1 approved / phase 42 preclinical / unstaged
Compare the share prices of listed companies in Transfusion-Dependent Beta Thalassemia →
Market size not yet sourced. How markets are sized ↗